Biblio

Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is H  [Clear All Filters]
2023
Zhang X, Che Y, Zhang T, Mao L, Li D, Deng J, Guo Y, Zhao Q, Zhang X, Gao X, et al. H3.3B controls aortic dissection progression by regulating vascular smooth muscle cells phenotypic transition and vascular inflammation. Genomics. 2023:110685.
Wei L, Yang X, Wang J, Wang Z, Wang Q, Ding Y, Yu A. H3K18 lactylation of senescent microglia potentiates brain aging and Alzheimer's disease through the NFκB signaling pathway. J Neuroinflammation. 2023;20(1):208.
Yu Y, Li X, Jiao R, Lu Y, Jiang X, Li X. H3K27me3-H3K4me1 transition at bivalent promoters instructs lineage specification in development. Cell Biosci. 2023;13(1):66.
Hoetker MS, Yagi M, Di Stefano B, Langerman J, Cristea S, Wong LPing, Huebner AJ, Charlton J, Deng W, Haggerty C, et al. H3K36 methylation maintains cell identity by regulating opposing lineage programmes. Nat Cell Biol. 2023.
Ding Y, Gao X, Zhao J, Zhi Q, Liu X, Zuo Q, Jin K, Zhang Y, Niu Y, Han W, et al. H3K4me2 cooperates with Wnt/TCF7L2 to regulate TDRD1 and promote chicken spermatogonia stem cell formation. Poult Sci. 2023;102(4):102552.
Wang H, Fan Z, Shliaha PV, Miele M, Hendrickson RC, Jiang X, Helin K. H3K4me3 regulates RNA polymerase II promoter-proximal pause-release. Nature. 2023.
Pal D, Patel M, Boulet F, Sundarraj J, Grant OA, Branco MR, Basu S, Santos SDM, Zabet NRadu, Scaffidi P, et al. H4K16ac activates the transcription of transposable elements and contributes to their cis-regulatory function. Nat Struct Mol Biol. 2023.
Breznak SM, Peng Y, Deng L, Kotb NM, Flamholz Z, Rapisarda IT, Martin ET, LaBarge KA, Fabris D, Gavis ER, et al. H/ACA snRNP-dependent ribosome biogenesis regulates translation of polyglutamine proteins. Sci Adv. 2023;9(25):eade5492.
Ghersi JJ, Baldissera G, Hintzen J, Luff SA, Cheng S, Xia IFan, Sturgeon CM, Nicoli S. Haematopoietic stem and progenitor cell heterogeneity is inherited from the embryonic endothelium. Nat Cell Biol. 2023.
Mariottini A, De Matteis E, Cencioni MTeresa, Muraro PA. Haematopoietic Stem Cell Transplantation for the Treatment of Multiple Sclerosis: Recent Advances. Curr Neurol Neurosci Rep. 2023.
Jackson JT, Nutt SL, McCormack MP. The Haematopoietically-expressed homeobox transcription factor: roles in development, physiology and disease. Front Immunol. 2023;14:1197490.
Errichiello S, Di Lorenzo S, Visintini C, Venturini M, Fabbro CMazzega, Petean M, Comuzzi C, Cerne D. [Haemopoietic stem cells transplantation: a narrative review]. Assist Inferm Ric. 2023;42(1):36-50.
Yang H, Zhang Y, Du Z, Wu T, Yang C. Hair follicle mesenchymal stem cell exosomal lncRNA H19 inhibited NLRP3 pyroptosis to promote diabetic mouse skin wound healing. Aging (Albany NY). 2023;15.
Tao R, Mi B, Hu Y, Lin S, Xiong Y, Lu X, Panayi AC, Li G, Liu G. Hallmarks of peripheral nerve function in bone regeneration. Bone Res. 2023;11(1):6.
Jin S, Li K, Zong X, Eun S, Morimoto N, Guo S. Hallmarks of Skin Aging: Update. Aging Dis. 2023.
Wiedmann L, Rigotti FDe Angelis, Vaquero-Siguero N, Donato E, Espinet E, Moll I, Alsina-Sanchis E, Bohnenberger H, Fernandez-Florido E, Mülfarth R, et al. HAPLN1 potentiates peritoneal metastasis in pancreatic cancer. Nat Commun. 2023;14(1):2353.
Yuan F, Li G, Li M, Wei X, Fu Y. Haplo-Cord transplantation with 8mg/kg anti-thymocyte globulin as graft-versus-host disease prophylaxis compared to haploidentical transplantation with 10mg/kg anti-thymocyte globulin in the treatment of acute leukemia. Transplant Cell Ther. 2023.
Feng J, Hsu P-F, Esteva E, Labella R, Wang Y, Khodadadi-Jamayran A, Pucella JNicholas, Liu CZ, Arbini AA, Tsirigos A, et al. Haplodeficiency of the 9p21 Tumor Suppressor Locus Causes Myeloid Disorders Driven by the Bone Marrow Microenvironment. Blood. 2023.
Gomez-Arteaga A, Orfali N, Pasciolla M, Baptiste A, Guindine I, Hsu J, Lin J, Mayer SA, Phillips AA, Shore TB, et al. Haploidentical allogeneic stem cell transplantation with post-transplant cyclophosphamide and subsequent kidney transplant for patients with severe sickle cell disease with end-stage kidney disease (ESKD). Bone Marrow Transplant. 2023.
Pury S, Orozco MLópez, Pichichero G, Sasia LV, Morell D, Álvarez MS, Basquiera AL, Mas ME, Salvucci K. Haploidentical bone marrow transplantation in a pediatric patient with Wiskott-Aldrich syndrome. A case report. Arch Argent Pediatr. 2023:e202310061.
Quintero V, Bueno-Sánchez D, Del Castillo YMozo-, Urtasun-Erburu A, Sisinni L, López-Duarte M, Pérez-Hurtado JMaría, Fuster JLuis, González-Vicent M, Pérez-Martínez A, et al. Haploidentical haematopoietic stem cell transplant in paediatric patients with acquired hypocellular bone marrow failures. Transplant Cell Ther. 2023.
Braun A, Liu L, Malki MMAl, Becker PS. Haploidentical hematopoietic cell transplant recipient presents with late-onset Epstein Barr virus-associated posttransplant lymphoproliferative disorder. EJHaem. 2023;4(3):848-851.
Kulkarni U, Arunachalam AKumar, Palani HKumar, Nair RRadhakrish, Balasundaram N, Venkatraman A, Korula A, Selvarajan S, Lionel S, Balasubramanian P, et al. Haploidentical Natural Killer Cell Therapy as an Adjunct to Stem Cell Transplantation for Treatment of Refractory Acute Myeloid Leukemia. Cell Transplant. 2023;32:9636897231198178.
Ruttens D, Philippet P, Bucciol G, Meyts I. Haploidentical Stem Cell Transplantation with Post-transplantation Cyclophosphamide in High-Risk Chronic Granulomatous Disease Patient with Invasive Mucormycosis. J Clin Immunol. 2023.
Wu H, Zhao Y, Gao F, Shi J, Luo Y, Yu J, Lai X, Liu L, Fu H, Qian P, et al. Haploidentical transplants deliver equal outcomes to matched sibling transplants: a propensity score-matched analysis. J Transl Med. 2023;21(1):329.

Pages